Cryo Cell International (CCEL) Operating Expenses (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Operating Expenses data on file, last reported at $6.9 million in Q1 2026.

• Quarterly Operating Expenses changed 0.07% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $31.1 million (up 9.52% YoY) and the FY2025 annual result came in at $31.1 million, up 9.04% from the prior year.
• Operating Expenses retreated to $6.9 million in Q1 2026 per CCEL's latest filing, from $11.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $24.1 million in Q4 2023 and bottomed at $5.8 million in Q1 2022.
• The 5-year median for Operating Expenses is $6.7 million (2022), against an average of $8.0 million.
• The widest annual swing landed in 2023, when Operating Expenses jumped 226.86%; it then tumbled 66.13% in 2024.
• Tracing CCEL's Operating Expenses over 5 years: stood at $7.4 million in 2022, then jumped by 226.86% to $24.1 million in 2023, then slumped by 66.13% to $8.1 million in 2024, then soared by 44.97% to $11.8 million in 2025, then sank by 41.42% to $6.9 million in 2026.
• Per Business Quant, the three latest CCEL Operating Expenses figures stand at $6.9 million (Q1 2026), $11.8 million (Q4 2025), and $5.9 million (Q3 2025).

Peer Comparison